Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894023816> ?p ?o ?g. }
- W2894023816 endingPage "1896" @default.
- W2894023816 startingPage "1884" @default.
- W2894023816 abstract "IntroductionProgrammed death 1/programmed death ligand 1 (PD-L1) axis inhibitors have been proven effective, especially in patients with tumors expressing PD-L1. Their clinical efficacy in patients with EGFR-activating mutations is still unclear, whereas KRAS mutations seem to be associated with good response.MethodsWe used multiplexed quantitative immunofluorescence to investigate PD-L1 expression and to characterize tumor infiltrating lymphocyte (TIL) populations and their activation status in more than 150 NSCLC patients with known mutation status.ResultsPD-L1 expression was significantly lower in EGFR-mutant compared to KRAS-mutant, and EGFR/KRAS wild-type (WT) tumors. KRAS mutant tumors were more inflamed with higher CD4+, CD8+ and CD20+ TILs. Subgroup analysis by TIL activation status revealed that EGFR mutants had a high frequency of inactive TILs even though lymphocytes were present in the tumor microenvironment. In contrast, in KRAS mutants, when TILs were present they were almost always active. Additionally, we found differences between EGFR mutation sites in CD8+ expression and the TIL activation profile. Finally, activated EGFR correlated with increased PD-L1 expression in EGFR mutants but not in EGFR WT, whereas TIL activation was associated with higher PD-L1 only in EGFR/KRAS WT.ConclusionsOur findings show the unique immune profile of EGFR-mutant tumors. The high frequency of inactive TILs could explain the low immunotherapy response rates in these patients, whereas PD-L1 as a predictive biomarker may reflect the constitutive oncogenic signaling rather than immune signaling, which would be associated with high PD-L1 levels and TILs activation." @default.
- W2894023816 created "2018-10-05" @default.
- W2894023816 creator A5002620104 @default.
- W2894023816 creator A5015800207 @default.
- W2894023816 creator A5019551393 @default.
- W2894023816 creator A5027326018 @default.
- W2894023816 creator A5027790861 @default.
- W2894023816 creator A5029434966 @default.
- W2894023816 creator A5039115208 @default.
- W2894023816 creator A5039160380 @default.
- W2894023816 creator A5058805895 @default.
- W2894023816 creator A5069499235 @default.
- W2894023816 date "2018-12-01" @default.
- W2894023816 modified "2023-10-16" @default.
- W2894023816 title "Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations" @default.
- W2894023816 cites W1510735640 @default.
- W2894023816 cites W1940241680 @default.
- W2894023816 cites W1967394241 @default.
- W2894023816 cites W1989790390 @default.
- W2894023816 cites W1992496728 @default.
- W2894023816 cites W1996374378 @default.
- W2894023816 cites W2004682614 @default.
- W2894023816 cites W2013090484 @default.
- W2894023816 cites W2025188134 @default.
- W2894023816 cites W2031373281 @default.
- W2894023816 cites W2039123767 @default.
- W2894023816 cites W2041560123 @default.
- W2894023816 cites W2049491375 @default.
- W2894023816 cites W2049553585 @default.
- W2894023816 cites W2066671159 @default.
- W2894023816 cites W2089228335 @default.
- W2894023816 cites W2101653483 @default.
- W2894023816 cites W2104347254 @default.
- W2894023816 cites W2104453868 @default.
- W2894023816 cites W2104885590 @default.
- W2894023816 cites W2106642283 @default.
- W2894023816 cites W2123918574 @default.
- W2894023816 cites W2124427232 @default.
- W2894023816 cites W2130256619 @default.
- W2894023816 cites W2142850084 @default.
- W2894023816 cites W2145411470 @default.
- W2894023816 cites W2147592245 @default.
- W2894023816 cites W2149668671 @default.
- W2894023816 cites W2152061559 @default.
- W2894023816 cites W2156353875 @default.
- W2894023816 cites W2160834915 @default.
- W2894023816 cites W2164001237 @default.
- W2894023816 cites W2168635759 @default.
- W2894023816 cites W2170423927 @default.
- W2894023816 cites W2198093519 @default.
- W2894023816 cites W2210073947 @default.
- W2894023816 cites W2289712604 @default.
- W2894023816 cites W2293531514 @default.
- W2894023816 cites W2306930734 @default.
- W2894023816 cites W2400514548 @default.
- W2894023816 cites W2444016033 @default.
- W2894023816 cites W2460489846 @default.
- W2894023816 cites W2489543948 @default.
- W2894023816 cites W2517195758 @default.
- W2894023816 cites W2518412322 @default.
- W2894023816 cites W2527905628 @default.
- W2894023816 cites W2544109448 @default.
- W2894023816 cites W2560367415 @default.
- W2894023816 cites W2572174216 @default.
- W2894023816 cites W2603352326 @default.
- W2894023816 cites W2608102145 @default.
- W2894023816 cites W2767720378 @default.
- W2894023816 cites W2777461561 @default.
- W2894023816 cites W2787467961 @default.
- W2894023816 cites W2797675588 @default.
- W2894023816 cites W2805354595 @default.
- W2894023816 cites W2886320197 @default.
- W2894023816 cites W2890663189 @default.
- W2894023816 cites W2890890452 @default.
- W2894023816 doi "https://doi.org/10.1016/j.jtho.2018.09.012" @default.
- W2894023816 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6251746" @default.
- W2894023816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30267840" @default.
- W2894023816 hasPublicationYear "2018" @default.
- W2894023816 type Work @default.
- W2894023816 sameAs 2894023816 @default.
- W2894023816 citedByCount "74" @default.
- W2894023816 countsByYear W28940238162019 @default.
- W2894023816 countsByYear W28940238162020 @default.
- W2894023816 countsByYear W28940238162021 @default.
- W2894023816 countsByYear W28940238162022 @default.
- W2894023816 countsByYear W28940238162023 @default.
- W2894023816 crossrefType "journal-article" @default.
- W2894023816 hasAuthorship W2894023816A5002620104 @default.
- W2894023816 hasAuthorship W2894023816A5015800207 @default.
- W2894023816 hasAuthorship W2894023816A5019551393 @default.
- W2894023816 hasAuthorship W2894023816A5027326018 @default.
- W2894023816 hasAuthorship W2894023816A5027790861 @default.
- W2894023816 hasAuthorship W2894023816A5029434966 @default.
- W2894023816 hasAuthorship W2894023816A5039115208 @default.
- W2894023816 hasAuthorship W2894023816A5039160380 @default.
- W2894023816 hasAuthorship W2894023816A5058805895 @default.
- W2894023816 hasAuthorship W2894023816A5069499235 @default.
- W2894023816 hasBestOaLocation W28940238161 @default.